Home > Publications database > H3.3-K27M drives neural stem cell-specific gliomagenesis in a human iPSC-derived model. |
Journal Article | DKFZ-2021-00304 |
; ; ; ; ; ; ; ; ; ; ;
2021
Elsevier
New York, NY
This record in other databases:
Please use a persistent id in citations: doi:10.1016/j.ccell.2021.01.005
Abstract: Diffuse intrinsic pontine glioma (DIPG) is an aggressive childhood tumor of the brainstem with currently no curative treatment available. The vast majority of DIPGs carry a histone H3 mutation leading to a lysine 27-to-methionine exchange (H3K27M). We engineered human induced pluripotent stem cells (iPSCs) to carry an inducible H3.3-K27M allele in the endogenous locus and studied the effects of the mutation in different disease-relevant neural cell types. H3.3-K27M upregulated bivalent promoter-associated developmental genes, producing diverse outcomes in different cell types. While being fatal for iPSCs, H3.3-K27M increased proliferation in neural stem cells (NSCs) and to a lesser extent in oligodendrocyte progenitor cells (OPCs). Only NSCs gave rise to tumors upon induction of H3.3-K27M and TP53 inactivation in an orthotopic xenograft model recapitulating human DIPGs. In NSCs, H3.3-K27M leads to maintained expression of stemness and proliferative genes and a premature activation of OPC programs that together may cause tumor initiation.
Keyword(s): DIPG ; H3.3-K27M ; H3K27me3 ; H3K4me3 ; NSC ; OPC ; bivalent chromatin ; glioma ; iPSC ; orthotopic xenograft
![]() |
The record appears in these collections: |